Skip to content
Catalyst

knowcompoundsCHEBI:15765

Specimen compoundPlate I

CHEBI:15765

The naturally occurring form of dihydroxyphenylalanine and the immediate precursor of dopamine.

Continue

Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. It is used for the treatment of parkinsonian disorders and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.”

Nested hairline contours trace the electron density of one computed shape of CHEBI:15765, teal at the edge warming to amber over the atoms.
fig. 1CHEBI:15765 · electron density · PubChem CID 6047, computed 3D conformer
PubChem CID
6047

01 · the reference layer, drawn

What it is linked to

reference statements, inferred one hop away · no finding · no strength

Fig. 2 CHEBI:15765 CHEBI:15765 10 neighbours 11 reference statements · no finding
×1.60
Labels
CompoundInspector

CHEBI:15765

Reference statements drawn

11statements · 10 neighbours

no finding, so no strength

Show all 10 neighboursHide the 10 neighbours
  • CHEBI:17895×2
  • COMT×1
  • DDC×1
  • Dopamine×1
  • L-dopaquinone×1
  • LRTOMT×1
  • SLC16A10×1
  • SLC3A2×1
  • SLC7A5×1
  • TYR×1
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

02 · reach

What it touches on the way

5 entities · assembled from reference reactions

  1. COMTProtein35 paths · 35 endpointsinferred
  2. DDCProtein19 paths · 19 endpointsinferred
  3. SLC3A2Protein12 paths · 12 endpointsinferred
  4. TYRProtein11 paths · 11 endpointsinferred
  5. SLC7A5Protein8 paths · 8 endpointsinferred

Where it reaches

6 regions · transporter routes

  1. Airway and sinusesrespiratory1 routeinferred
  2. Brainnervous1 routeinferred
  3. Eyenervous1 routeinferred
  4. Mouth and oesophagusdigestive1 routeinferred
  5. Nerve and spinal cordnervous1 routeinferred
  6. Pancreasendocrine1 routeinferred

03 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
1101 ProteinSLC16A10, SLC3A2, SLC7A5, DDC, LRTOMT, TYR, and 1 more02 CompoundCHEBI:17895, dopamine, L-dopaquinoneinferred, one hop from CHEBI:15765
Reactions · Rhea
12reactions
11Reference statements

What the reference databases state

Evidence key

Statements

11 statements

12Reactions

04 · on the label · 1 product

Labelled products

Source: NIH DSLD · Ingredient: CHEBI:15765 · 1 product · Declared amount per serving: 10–10 mg

1 label states an amount0 do not

  • MetagenicsHisSynergystandardized to 20% levodopa10 mgper 1 tabletDSLD:295749

Label record: NIH Office of Dietary Supplements · CC0

05 · the record

Sources

Other names · 15

(-)-3-(3,4-dihydroxyphenyl)-L-alanine · (-)-dopa · (−)-3-(3,4-dihydroxyphenyl)-L-alanine · (−)-dopa · 3-Hydroxy-L-tyrosine · 3,4-Dihydroxy-L-phenylalanine · 3,4-DIHYDROXYPHENYLALANINE · β-(3,4-dihydroxyphenyl)-L-alanine · β-(3,4-dihydroxyphenyl)alanine · Dihydroxy-L-phenylalanine · L-beta-(3,4-Dihydroxyphenyl)alanine · levodopa

systematic · (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid

systematic · L-dopa

sold as · Dopar